ABSTRACT
This chapter will review the current knowledge
on genetic testing in AD based on chapter 5
from the 1st edition of Management of
Dementia, written by Simon Lovestone, with
new insight into pharmacogenomics, e.g., how
genes can influence response to treatment.
